What should I pay attention to when using dacomitinib (dacomitinib)? Are there any dietary, medication or lifestyle restrictions?

Dacomitinib is an irreversible EGFR tyrosine kinase inhibitor (TKI), mainly used to treat EGFR mutation-positive non-small cell lung cancer (NSCLC). As a more potent generation of EGFR-TKI, dacomitinib has shown better efficacy than the generation of EGFR inhibitors (such as gefitinib) in clinical trials, but it also brings a higher risk of adverse reactions. Therefore, when using dacomitinib, patients need to pay attention to multiple aspects, including dose adjustment, possible side effects, diet and drug interactions, lifestyle habits, etc., to ensure the safety and effectiveness of the treatment.

1. Dose and Adjustment

The standard recommended dose of dacomitinib is 45 mg once daily, which can be taken on an empty stomach or with food. If the patient experiences severe side effects (such as severe diarrhea, rash, stomatitis, etc.), the doctor may reduce the dose to 30 mg or 15 mg depending on the situation to improve tolerance. Patients should not increase or decrease the dosage or discontinue the medication on their own while taking the medication. If they feel uncomfortable, they should communicate with their doctor in time to adjust the plan.

In addition, dacomitinib is mainly metabolized by the liver, so patients with abnormal liver function need to use it with caution under the guidance of a doctor. At the same time, elderly patients and patients with impaired renal function may require additional monitoring to assess drug metabolism and tolerability.

2. Possible side effects and management

Common side effects of dacomitinib include skin toxicity (rash, itching, dry skin), diarrhea, stomatitis, nail changes, eye discomfort, etc. Among them, rash and diarrhea are the most common adverse reactions, which may occur in most patients in the early stages of treatment (within 1-2 weeks) and require active management:

Rash management: It is recommended to use a mild moisturizer and avoid harsh skin care products or intense sun exposure. If the rash is severe, your doctor may recommend topical antibiotics, anti-inflammatory drugs, or a short course of oral antibiotics (such as minocycline, azithromycin).

Diarrhea management: Adequate fluid intake should be maintained and high-fat, spicy and high-fiber foods should be avoided. If the diarrhea is severe, antidiarrheal drugs (such as loperamide) can be used under the guidance of a doctor.

Stomatitis: You can rinse your mouth with warm water, avoid spicy and hot foods, and use an appropriate amount of local anesthetic gargle (such as lidocaine) to relieve pain.

In addition, a small number of patients may develop pneumonia, abnormal liver function, or adverse cardiovascular events. Therefore, liver function, pulmonary function, and electrocardiogram should be checked regularly while taking the drug. If symptoms such as unexplained persistent cough, dyspnea, and jaundice occur, you should seek medical attention immediately.

3. Dietary Precautions

There are no strict dietary contraindications for dacomitinib, but in order to improve tolerance and reduce adverse reactions, it is recommended to pay attention to the following points:

Avoid spicy, greasy, and high-fiber foods to reduce gastrointestinal irritation and reduce the risk of diarrhea.

Eating more foods rich in vitamins A and E (such as carrots and nuts) can help improve dry skin and rash problems.

Increase high-quality protein (such as fish, eggs, soy products) to enhance the body's resistance and reduce the consumption of drugs on the body.

Avoid alcohol, strong tea, and coffee, as alcohol may burden the liver, while caffeine may irritate the gastrointestinal tract.

4. Drug interactions and lifestyle adjustments

Dacomitinib may interact with certain drugs, affecting its efficacy or increasing the risk of adverse reactions. Patients need to pay special attention to the following while taking the drug:

Avoid concurrent use with strongCYP2D6 inhibitors (such as paroxetine, fluoxetine), otherwise it may increase the blood concentration of dacomitinib and worsen side effects.

Avoid long-term concomitant use with antacids (such as omeprazole, rabeprazole), as these drugs may affect the absorption of dacomitinib. If necessary, antacids should be taken at least 6 hours before or 2 hours after taking dacomitinib.

Use anticoagulants such as warfarin with caution as dacomitinib may affect coagulation and increase the risk of bleeding.

In terms of living habits, patients should try to avoid prolonged exposure to the sun, as dacomitinib may cause photosensitivity dermatitis. It is recommended to apply sunscreen and wear protective clothing when going out. In addition, patients should maintain good work and rest habits and avoid staying up late and overexertion to improve the body's tolerance to the drug.

Dacomitinib, as a second-generation EGFR-TKI, plays an important role in EGFRThe treatment of mutation-positive non-small cell lung cancer has a high efficacy, but it is also accompanied by strong adverse reactions. Therefore, patients must strictly follow the doctor's dosage adjustment recommendations during use and pay attention to the management of common side effects, such as rash, diarrhea, stomatitis, etc. In addition, you need to avoid spicy and irritating foods in your diet, avoid exposure to the sun in your daily life, and use drugs that may cause drug interactions with caution. During treatment, regular monitoring of liver function, lung function and cardiovascular status can help ensure safe medication use and improve treatment effects. With appropriate management, patients can better tolerate dacomitinib, resulting in longer survival and better quality of life.

Reference materials:https://www.pfizer.com/products/product-detail/vizimpro